If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common stock, par value $0.0001 per share ("Common Stock") outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission ("SEC") on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percent of class is calculated based on 17,539,937 shares of Common Stock outstanding as of November 10, 2025, as reported in the Issuer's Form 10-Q filed with the SEC on November 12, 2025. The reported amounts reflect the 1-for-5 reverse stock split effected by the Issuer on July 1, 2024 of its Common Stock.


SCHEDULE 13D


 
ABRY Partners VII, L.P.
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
ABRY Partners VII Co-Investment Fund, L.P.
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
ABRY Investment Partnership, L.P.
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
ABRY Senior Equity IV, L.P.
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
ABRY Senior Equity Co-Investment Fund IV, L.P.
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
ABRY Partners II, LLC
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
Royce Yudkoff
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
Peggy Koenig
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026
 
Jay Grossman
 
Signature:/s/ Kostas Sofronas
Name/Title:Kostas Sofronas / Attorney-in-Fact
Date:03/02/2026